CONTROLLING OF IMMUNE ACTIVATION BY SOLUBLE CLEVER-1

Altering levels of soluble CLEVER-1 in circulation achieves either immune activation or immune-suppression of T cells in an individual. Soluble CLEVER-1 has been found to bind to activated T cells using Receptor of Activated Protein C Kinase 1 (RACK1) as its ligand.

Saved in:
Bibliographic Details
Main Authors DE FIGUEIREDO, Carlos Rogerio ("Roger"), HOLLMÉN, Maija-Leena, JALKANEN, Juho
Format Patent
LanguageEnglish
Published 21.07.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Altering levels of soluble CLEVER-1 in circulation achieves either immune activation or immune-suppression of T cells in an individual. Soluble CLEVER-1 has been found to bind to activated T cells using Receptor of Activated Protein C Kinase 1 (RACK1) as its ligand.
Bibliography:Application Number: US202217577132